Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2003
10/02/2003US20030186369 Egg specific surface proteins
10/02/2003US20030186367 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030186366 For stimulating release of tumor necrosis factor and/or cellular differentiation of chondrocytes, endothelial cells or adipocytes by contacting blood with pro-polypeptide; cancer diagnosis and treatment
10/02/2003US20030186364 For producing vaccines for the prevention or attenuation of infection by Staphylococcus
10/02/2003US20030186363 Method for cloning and expression of BsaI restriction endonuclease and BsaI methylase in E. coli
10/02/2003US20030186359 Genes encoding insect odorant receptors and uses thereof
10/02/2003US20030186357 Vertebrate embryonic pattern-inducing proteins, and uses related thereto
10/02/2003US20030186356 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
10/02/2003US20030186343 Immunoglobulin which binds low density lipoprotein receptor for diagnosis, prevention or treatment of viral infections; viricides
10/02/2003US20030186337 Novel death associated proteins, and THAP1 and PAR4 pathways in apoptosis control
10/02/2003US20030186333 Comprises nervous system polypeptide for diagnosis, prognosis, treatment and evaluation of neurodegenerative disorders
10/02/2003US20030186332 CompriseS nucleotide sequences coding neurotrophic factor expression-inducing agent (PSEC56 protein) for designing therapies for treating nervous system disorders
10/02/2003US20030186329 Bacteriophage display library which comprises peptide substrates for elucidating specificity differences between closely related enzymes and making enzyme inhibitors based on those differences
10/02/2003US20030186325 Method of screening for inhibitors of osteopontin
10/02/2003US20030186322 Methods for display of heterodimeric proteins on filamentous phage using pVII and pIX, compositions, vectors and combinatorial libraries
10/02/2003US20030186321 Comprises polypeptide having antitumor, immunomodulatory and viricidal activity for treating leukemia, hepatitis and autoimmune diseases
10/02/2003US20030186314 SNP detection method and SNP detection apparatus
10/02/2003US20030186312 Method for synthesizing DNA
10/02/2003US20030186308 Prostacyclin-stimulating factor-2
10/02/2003US20030186307 Propagating and replicating procine circoviruses (PCV) for use in vaccine development and as diagnostic aides detecting viral infection in swine; animal husbandry
10/02/2003US20030186305 Novel proteins
10/02/2003US20030186304 Comprises protein for diagnosis and treatment of cardiovascular disorders
10/02/2003US20030186303 Detecting colon and rectum cancers by identifying and evaluating differential modulation in the gene expression profiles of carcinoembryonic antigens or guanylyl cyclase tumor marker genes
10/02/2003US20030186302 Detecting colon and rectum cancers by identifying and evaluating differential modulation in the gene expression profiles of carcinoembryonic antigens or guanylyl cyclase tumor marker genes
10/02/2003US20030186301 Synthesizing oligonucleotide sequences for use as tools in polymerase chain reaction, in situ hhybridization, gene transfection and mutagenesis
10/02/2003US20030186298 Microarray for detecting and monitoring binding of biopolymers such as DNA and proteins; drug screening; diagnosing genetic disorders
10/02/2003US20030186294 Method of diagnosing and treating lesion of crystalline lens using human crygs gene and coding product thereof
10/02/2003US20030186292 Methods for identifying DNA molecules that encode a natural product having bioactivity or encode a protein involved in the production of natural product having bioactivity
10/02/2003US20030186290 Gene involved in CADASIL, method of diagnosis and therapeutic application
10/02/2003US20030186289 Model cell systems for screening of anti-hypertrophic therapeutics
10/02/2003US20030186286 Suppressor of cytokine signaling (SOCS)-3 promoter and methods for its use in genetic therapy in humans
10/02/2003US20030186284 Method of screening ptp ç activitiy promoter or inhibitor
10/02/2003US20030186281 Modified tetracycline repressor protein compositions and methods of use
10/02/2003US20030186277 Nucleic acids for diagnosis of cancer, rheumatic diseases, arthritic, skin and blood disorders 0
10/02/2003US20030186275 Using bacterial peptides to develop vaccine to protect against mycobacterium infections
10/02/2003US20030186270 Compositions and methods for reverse transcription of nucleic acid molecules
10/02/2003US20030186269 Ssa-56 kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
10/02/2003US20030186266 Highly sensitive nucleic acid hybridization method and gene analysis method by using the same
10/02/2003US20030186264 Comprises enzymatic polypeptide for diagnosis and treatment of genetic disorders; drug screening; immunoassay; high throughput assay
10/02/2003US20030186263 Apparatus comprising electrodes coupled to probes for detecting DNA, proteins or peptides
10/02/2003US20030186262 Novel dna chips
10/02/2003US20030186261 Method of increasing complementarity in a heteroduplex
10/02/2003US20030186258 Comprises protease (KEX1) for processing fusion proteins containing peptides or proteins of industrial and/or therapeutic interest; biocatalysts
10/02/2003US20030186257 Using biopolymer to mark and code preferential objects; fluorescence microscope; hairpin structures
10/02/2003US20030186253 Fibroblast growth factor-13
10/02/2003US20030186252 Array based hybridization assays employing enzymatically generated labeled target nucleic acids and compositions for practicing the same
10/02/2003US20030186246 Using polymerase chain reation to evaluate gene expression in small biological samples such as cancerous lesions in the lung, breast, prostate, thyroid and pancreas
10/02/2003US20030186244 Using stored nucleotide sequence information to screen genome databases to detect restriction fragment length polymorphisms which are associated with genetic disorders
10/02/2003US20030186238 RNA detection assays
10/02/2003US20030186237 Methods and compositions of amplifying RNA
10/02/2003US20030186236 Diagnosis and prevention of infectibity of swine with porcine reproductive and respiratory syndrome virus; viricides; animal husbandry
10/02/2003US20030186234 Methods and compositions for generation of multiple copies of nucleic acid sequences and methods of detection thereof
10/02/2003US20030186233 Nucleotide sequences coding topoisomerase binding sites for use in vector for concurrent recombinational cloning of two or more DNA sequences
10/02/2003US20030186232 Human and non-human primate homologues of Nkd protein, nucleic acid sequences encoding, and uses thereof
10/02/2003US20030186231 Systematic evolution of ligands by exponential enrichment: Chemi-ESLEX
10/02/2003US20030186229 Emission ratiometric indicators of phosphorylation
10/02/2003US20030186226 Methods and compositions for economically synthesizing and assembling long DNA sequences
10/02/2003US20030186225 Comprises DNA sequences coding viral protein for use in developing vaccine which prevents porcine reproductive and respiratory syndrome viral infections
10/02/2003US20030186224 CD4+ T-lymphocyte-specific hepatitis C virus-epitopes
10/02/2003US20030186223 Modular recombinatorial display libraries
10/02/2003US20030186221 Using microarrays to monitor sensitivity and competetive binding activities associated with viral peptide and fusion proteins
10/02/2003US20030185935 Method for producing breads
10/02/2003US20030185898 Cartilage-Derived morphogenetic proteins
10/02/2003US20030185890 Compositions and methods for polynucleotide delivery
10/02/2003US20030185879 Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
10/02/2003US20030185870 Oligopeptide binding agent including a first ligand that specifically binds a non-biological substrate and a second ligand that specifically binds a biological substrate.
10/02/2003US20030185859 Lyme disease vaccine
10/02/2003US20030185855 Which has lost its transducing properties as a result of a DNA sequence change in the gene coding for Vmw65 protein; expressable heterologous gene inserted; under the control of the immediate early 1 gene enhancer of cytomegalovirus
10/02/2003US20030185852 Parasitic protozoan isolate
10/02/2003US20030185851 Tet transactivator system
10/02/2003US20030185849 React with convalescent phase antiserum from an E. canis-infected dog; useful in the development of vaccines and serodiagnostics
10/02/2003US20030185848 Using such isolated antigens for producing immune responses in bovines or other non-human animals.
10/02/2003US20030185845 Such as variants of interleukin 5 and tumour necrosis factor alpha
10/02/2003US20030185842 Heat shock protein-based vaccines and immunotherapies
10/02/2003US20030185836 Cryptosporidium sporozoite antigens
10/02/2003US20030185830 Compositions and methods for the therapy and diagnosis of prostate cancer
10/02/2003US20030185829 Jagged 2 inhibitors for inducing apoptosis
10/02/2003US20030185828 For treating osteoarthritis
10/02/2003US20030185825 Novel immunotoxins and methods of inducing immune tolerance
10/02/2003US20030185823 Arming of activated T cells with BiAbs increases the effective precursor frequency of CTL in the cancer patient.
10/02/2003US20030185821 Antibodies to interleukin-4 receptors and uses thereof
10/02/2003US20030185820 Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same, and methods of use thereof
10/02/2003US20030185819 Treatment of specific and non-specific inflammation, including asthma; useful in diagnosing and localizing sites of inflammation.
10/02/2003US20030185818 Humanized antibody against cd18
10/02/2003US20030185815 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
10/02/2003US20030185814 Ceramidase
10/02/2003US20030185810 Tumor radiosensitization using gene therapy
10/02/2003US20030185809 First population of mammalian cells transfected or transduced with a gene that is sought to be expressed, and a second population of mammalian cells that have not been transfected or transduced with the gene
10/02/2003US20030185802 DNA construct operably encoding a vascular endothelial growth factor receptor protein.
10/02/2003US20030185801 Packaging cell line capable of complementing recombinant adenoviruses based on serotypes from subgroup B, preferably adenovirus type 35.
10/02/2003US20030185800 Human interferon-epsilon: a type I interferon
10/02/2003US20030185797 Synferon
10/02/2003US20030185790 Methods of ex-vivo expansion of hematopoeitic cells using multivariant IL-3 hematopoiesis chimera proteins
10/02/2003CA2517582A1 Saccharomyces cerevisiae yeast strain with improved phytase activity
10/02/2003CA2491495A1 Storing and detecting nucleic acid administered to a solid carrier
10/02/2003CA2484044A1 Imidazoquinolineamines as adjuvants in hiv dna vaccination
10/02/2003CA2480099A1 Erbb3 based methods and compositions for treating neoplasms
10/02/2003CA2480050A1 Tenascin-w compositions and uses thereof
10/02/2003CA2480016A1 Histone deacetylase: novel molecular target of neurotoxicity
10/02/2003CA2479908A1 Calcineurin activator
1 ... 2409 2410 2411 2412 2413 2414 2415 2416 2417 2418 2419 2420 2421 2422 2423 2424 2425 2426 2427 2428 2429 ... 4023